Cost utility of photodynamic therapy for predominantly classic neovascular age related macular degeneration

Background/aim: Age related macular degeneration (AMD) is the leading cause of severe vision impairment and blindness in older people throughout the developed world and currently affects around 420 000 UK citizens. Choroidal neovascularisation (CNV) is treatable with photodynamic therapy (PDT) but i...

Full description

Saved in:
Bibliographic Details
Main Authors: Hopley, C, Salkeld, G, Mitchell, P
Format: Article
Language:English
Published: Copyright 2004 British Journal of Ophthalmology 2004
Subjects:
Value Based Ophthalmology
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC1772258/
https://ncbi.nlm.nih.gov/pubmed/15258009
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bjo.2003.039131
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://ncbi.nlm.nih.gov/pmc/articles/PMC1772258/
https://ncbi.nlm.nih.gov/pubmed/15258009
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bjo.2003.039131

Similar Items